Clinical Trial Update: Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether eslicarbazepine acetate affects cardiac repolarization in epilepsy patients; the study completed and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-22